Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s displayed revision/build number has been updated from **v3.5.2** to **v3.5.3** for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page history shows a new revision entry (v3.4.2) replacing v3.4.1, with no other content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check93 days agoChange DetectedThe record history now shows Revision: v3.4.1 added and Revision: v3.4.0 removed. This is a minor versioning update reflected in the history list.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.